Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer

Carolyn D. Britten, Alex A. Adjei, Robert Millham, Brett E. Houk, Gary Borzillo, Kristen J. Pierce, Zev A. Wainberg, Patricia LoRusso

Investigational New Drugs · 2014 · 76 citations · 15 references

Concepts

References

15